India, Feb. 8 -- Thermo Fisher Scientific has received 510(k) clearance from the US Food & Drug Administration (FDA) for theApplied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel, offering a single clinical testing solution for four of the most common respiratory viruses circulating in flu season.

This real-time PCR-based multiplex test covers the detection and differentiation of SARS-CoV-2, influenza A virus, influenza B virus, and respiratory syncytial virus (RSV) and enables detection of co-infection.

Respiratory infections often present with overlapping signs of infection, making it difficult to accurately differentiate between common respiratory viral infections and therefore detect the specific pathogen responsible fo...